Skip to main content

COMMERCE BANK

Bank

Position in NBIX — Neurocrine Biosciences Inc

CIK 1009076 KANSAS CITY, MO

Position in NBIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,232,985
+$481,898 QoQ
Shares Held
13,249
-0.3% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#302
of 768 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 95% Shared 5% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

COMMERCE BANK holds $12,369,158 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (18.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
13,249 $2,232,985

All Filings in NBIX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,232,985 13,249
2026-03-31 $1,751,087 13,292
2025-12-31 $228,629 1,612
2025-09-30 $221,799 1,580
2024-09-30 $483,808 4,199
2024-06-30 $563,207 4,091
2022-03-31 $203,062 2,166
2021-06-30 $601,047 6,176
2021-03-31 $601,782 6,188
2020-12-31 $566,281 5,908
2020-09-30 $369,542 3,843
2020-06-30 $461,160 3,780
2020-03-31 $328,196 3,792